Search results

Page title matches

• Pharmacogenomics
  ...genetics">{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=Pharmacogenomics |title=Pharmacogenetics |accessdate=2008-01-22 |author=Anonymous |authorlin ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W |title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic
  5 KB (713 words) - 17:34, 10 February 2024
• Pharmacogenomics/Approval
  12 bytes (1 word) - 10:00, 23 January 2008
• Pharmacogenomics/Definition
  203 bytes (24 words) - 17:07, 14 May 2010
• Pharmacogenomics/External Links
  423 bytes (56 words) - 13:18, 24 July 2008
• Pharmacogenomics/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Pharmacogenomics]]. Needs checking by a human.
  608 bytes (78 words) - 19:29, 11 January 2010

Page text matches

• Pharmacogenetics
  #REDIRECT [[Pharmacogenomics]]
  30 bytes (2 words) - 12:04, 20 October 2008
• Traditional medicine/Related Articles
  {{r|Pharmacogenomics}}
  444 bytes (50 words) - 18:32, 3 January 2009
• Clinical decision support system/Related Articles
  {{r|Pharmacogenomics}}
  506 bytes (63 words) - 01:21, 13 March 2009
• HLA Antigens/Related Articles
  {{r|Pharmacogenomics}}
  472 bytes (60 words) - 17:02, 11 January 2010
• Abacavir/Related Articles
  {{r|Pharmacogenomics}}
  471 bytes (60 words) - 07:38, 8 January 2010
• Pharmacogenomics/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Pharmacogenomics]]. Needs checking by a human.
  608 bytes (78 words) - 19:29, 11 January 2010
• Cytochrome P-450/Related Articles
  {{r|Pharmacogenomics}}
  926 bytes (114 words) - 15:48, 11 January 2010
• Heart failure/Related Articles
  {{r|Pharmacogenomics}}
  2 KB (187 words) - 17:07, 11 January 2010
• G-protein-coupled receptor kinase
  ==Pharmacogenomics==
  5 KB (679 words) - 09:15, 29 August 2009
• Pharmacogenomics
  ...genetics">{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=Pharmacogenomics |title=Pharmacogenetics |accessdate=2008-01-22 |author=Anonymous |authorlin ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W |title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic
  5 KB (713 words) - 17:34, 10 February 2024
• Single-nucleotide polymorphism/External Links
  *[http://www.pharmgkb.org PharmGKB] — The Pharmacogenetics and Pharmacogenomics Knowledge Base, a resource for SNPs associated with drug response and dis
  2 KB (338 words) - 12:38, 29 January 2009
• Systems biology/External Links
  ...olution, signal transduction pathways and networks, stress responses and [[pharmacogenomics]] in cancer biology. Members of the group explore the linkage between theor
  3 KB (389 words) - 02:20, 12 January 2011
• Cytochrome P-450 CYP2D6
  ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W| title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic
  3 KB (483 words) - 17:34, 10 February 2024
• Traditional medicine
  ...ctive in their places of origin, the reasons for which may relate to the [[pharmacogenomics]] of the indigenous population.
  3 KB (421 words) - 22:32, 8 January 2009
• Food and Drug Administration/Related Articles
  {{r|Pharmacogenomics}}
  4 KB (505 words) - 16:36, 11 January 2010
• Cytochrome P-450
  ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W |title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W |title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic
  22 KB (2,960 words) - 17:35, 10 February 2024
• Chronic fatigue syndrome
  ...h empirically delineated classes of unexplained chronic fatigue. | journal=Pharmacogenomics | year= 2006 | volume= 7 | issue= 3 | pages= 387-94 | pmid=16610949 ...ne effector and receptor genes predict chronic fatigue syndrome. | journal=Pharmacogenomics | year= 2006 | volume= 7 | issue= 3 | pages= 475-83 | pmid=16610957
  14 KB (1,974 words) - 11:52, 2 February 2023
• Sympathetic nervous system
  ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W |title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic
  6 KB (767 words) - 17:34, 10 February 2024
• Cytochrome P-450 CYP2C19
  ...Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W |title=Potential role of pharmacogenomics in reducing drug-related side effects and adverse reactionss: a systematic
  8 KB (1,130 words) - 17:34, 10 February 2024
• Warfarin
  ====Pharmacogenomics==== ...ommon VKORC1 and GGCX polymorphisms associated with warfarin dose |journal=Pharmacogenomics J |volume=5 |pages=262-70 |year=2005 |pmid=15883587 }}</ref>: particular mu
  52 KB (7,136 words) - 22:53, 6 April 2014